112 related articles for article (PubMed ID: 24676601)
1. LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M; Hu W
Oncol Rep; 2014 May; 31(5):2454-60. PubMed ID: 24676601
[TBL] [Abstract][Full Text] [Related]
2. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.
Meng F; Li H; Zhou R; Luo C; Hu Y; Lou G
Biomarkers; 2013 Mar; 18(2):136-43. PubMed ID: 23312008
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
4. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
[TBL] [Abstract][Full Text] [Related]
5. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
Qiao M; Hu G
Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
[TBL] [Abstract][Full Text] [Related]
6. Association of LAPTM4B gene polymorphism with breast cancer susceptibility.
Fan M; Liu Y; Zhou R; Zhang Q
Cancer Epidemiol; 2012 Aug; 36(4):364-8. PubMed ID: 22270081
[TBL] [Abstract][Full Text] [Related]
7. Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer.
Wang S; Zhang QY; Zhou RL
Ann Oncol; 2012 Jul; 23(7):1864-9. PubMed ID: 22156622
[TBL] [Abstract][Full Text] [Related]
8. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
Liu Y; Zhang QY; Qian N; Zhou RL
Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
[TBL] [Abstract][Full Text] [Related]
9. LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.
Maki Y; Fujimoto J; Lang W; Xu L; Behrens C; Wistuba II; Kadara H
Sci Rep; 2015 Sep; 5():13846. PubMed ID: 26343532
[TBL] [Abstract][Full Text] [Related]
10. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.
Cheng XJ; Xu W; Zhang QY; Zhou RL
Ann Oncol; 2008 Mar; 19(3):527-32. PubMed ID: 17965115
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer].
Deng LJ; Zhang QY; Liu B; Zhou RL
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):302-5. PubMed ID: 15968325
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Chen X; Zhang N; Jiang L; Ma T; Yang Q
PLoS One; 2012; 7(9):e44916. PubMed ID: 22984585
[TBL] [Abstract][Full Text] [Related]
13. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.
Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967
[TBL] [Abstract][Full Text] [Related]
14. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
[TBL] [Abstract][Full Text] [Related]
15. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M
Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
[TBL] [Abstract][Full Text] [Related]
18. The relationship of metalloproteinase gene polymorphisms and lung cancer.
Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
20. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
